Ihr neues Infoportal.

Top news

Onkologie

Gilead's Research Scholars Program

10.10.2022

Jetzt bewerben!

Top news

Onkologie

PODCAST! ASCO Update 2022 – Fokus Mammakarzinom

24.08.2022

Vielgehört: Update Mammakarzinom Vol. 2

Top news

Onkologie

Sacituzumab Govitecan: Toxizität und Management

21.04.2022 Mehr lesen

Top news

Onkologie

Clinical trial

26.11.2021

Clinical trial - Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer

Ihre Ansprechpartner

Klaus-Jürgen Stolz

Simon Oberdorfer

Eva Pazdera

Expertenvideos

Sacituzumab Govitecan: Toxizität und Management

Medizinische Illustrationen

Facts and Figures_Breast cancer histological subtypes

Facts and Figures_Breast cancer intrinsic subtypes

Facts and Figures_Breast cancer US numbers

Facts and Figures_Common metastatic sites in breast cancer

Facts and Figures_Common side effects in breast cancer treatment

Facts and Figures_Tumor localization by frequency and sex AUT numbers

Facts and Figures_Tumor localization by frequency and sex US numbers

Mode of Action_Capecitabine

Mode of Action_Cdk4-6 Inhibitors

Mode of Action_Doxorubicin

Mode of Action_ER targeted therapy

Mode of Action_Eribulin

Mode of Action_Gemcitabine

Mode of Action_HER-2 targeted therapy

Mode of Action_PARP Inhibitors

Mode of Action_PD(L)-1 Inhibitors

Mode of Action_Sacituzumab Govitecan

Mode of Action_Taxane

Medizinische Slide Decks